← Open Payments lookup

GREGORY HAMRICK: Open Payments

NPI 1063476679 · TUSCALOOSA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$564 in 29 payments from 15 companies in 2025. Trend: 2023 $664 · 2024 $735 · 2025 $564

Food & beverage: $564
CompanyPaymentsAmount
Novo Nordisk Inc7$135
Novartis Pharmaceuticals Corporation5$107
Indivior Inc.2$55
Actelion Pharmaceuticals US, Inc.2$40
Bayer Healthcare Pharmaceuticals Inc.2$33
Lilly USA, LLC2$31
Otsuka America Pharmaceutical, Inc.1$28
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$22
Esperion Therapeutics, Inc.1$21
PFIZER INC.1$16

Products named: Wegovy, LEQVIO, SUBLOCADE, UPTRAVI, Kerendia, MOUNJARO, REXULTI, XIFAXAN.

Industry payments across AL — which companies pay providers there.